NIH-funded research R21 grant

How the FOXE3 gene controls eye lens development

Official title: Utilizing the Chicken Embryo to Decode the Transcriptional Regulation of FOXE3

Funded at Miami University Oxford · NIH-11261147 · Data updated 2026-11-12

Researchers will use chick embryos to map the DNA switches that turn the FOXE3 gene on in the eye lens to help people born with missing or small lenses (aphakia or microphthalmia).

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionMiami University Oxford
NIH-funded
Lab location1 site (Oxford, United States)
Project startFebruary 1, 2025
Project endJanuary 31, 2027
Funding year2026
Award (this year)$178,102
NIH project number5R21EY036999-02
Project IDNIH-11261147 on NIH RePORTER

Who could benefit from this research

Could help

People with congenital lens disorders (aphakia or microphthalmia) or families with known FOXE3 gene changes would be the most relevant patient group.

Less likely to help

People with common age-related cataracts or unrelated eye conditions are unlikely to see direct benefit from this basic laboratory research.

What this research studies

This project uses the chick embryo's simple, well-mapped lens to find the DNA control elements that tell the FOXE3 gene when and where to turn on. Scientists will combine genome-wide sequencing to identify candidate regulatory elements with functional tests in embryos to see which sequences are required for FOXE3 expression. They will compare these results to prior mouse data to build a regulatory "grammar" for how FOXE3 is controlled during lens development. The work is laboratory-based and uses animal embryos rather than enrolling patients directly.

Why it matters

Potential benefit: If successful, the work could improve genetic diagnosis and point to targets for future therapies for congenital lens disorders like aphakia and microphthalmia.

How similar studies have gone: Genome-wide mapping and chick embryo functional tests have identified regulatory elements for other eye genes, but functionally decoding FOXE3 in vivo is a newer application of these methods.

Where this research is happening

  • Miami University Oxford
    Oxford, United States
    Active

Researchers

  • Principal investigator: Robinson, Michael L — Miami University Oxford
  • Study coordinator: Robinson, Michael L

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.